JMP Group Declares Second Quarter 2017 Monthly Distributions

SAN FRANCISCO--(BUSINESS WIRE)-- JMP Group LLC (NYSE: JMP), an investment banking and alternative asset management firm, announced today that its board of directors has declared cash distributions of $0.03 per share for the months of April, May and June 2017. In total, the three monthly distributions equal $0.09 per share for the second quarter of the year.

The April distribution is payable on May 15, 2017, to shareholders of record as of April 28, 2017. The May distribution is payable on June 15, 2017, to shareholders of record as of May 31, 2017. The June distribution is payable on July 14, 2017, to shareholders of record as of June 30, 2017.

About JMP Group

JMP Group LLC is a diversified capital markets firm that provides investment banking, equity research, and sales and trading services to corporate and institutional clients as well as alternative asset management products and services to institutional and high-net-worth investors. JMP Group conducts its investment banking and research, sales and trading activities through JMP Securities; its hedge fund, venture and private capital, and credit management activities though Harvest Capital Strategies, JMP Asset Management and JMP Credit Advisors; and the management of Harvest Capital Credit Corporation (NASDAQ: HCAP), a business development company, through HCAP Advisors. For more information, visit www.jmpg.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170419006503/en/

Investor Relations Contact
JMP Group LLC
Andrew Palmer, 415-835-8978
[email protected]
or
Media Relations Contacts
Dukas Linden Public Relations, Inc.
Seth Linden, 212-704-7385
[email protected]
Ben Jaffe, 212-704-7385
[email protected]

Source: JMP Group LLC

You May Also Be Interested In

• Xtract One to Participate in Upcoming Planet MicroCap Conference
• Eventus wins Best Trade Surveillance Solution at TradingTech Insight Awards USA 2026
• Rocket Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $180 Million